Methylation of individual CpG sites within p16 CpG islands in various human gastric lesions Zheming Lu( 陆哲明) Dajun Deng (邓大君) Beijing University School.

Slides:



Advertisements
Similar presentations
Epigenetics Epigenetics - Heritable changes in gene expression that operate outside of changes in DNA itself - stable changes in gene expression caused.
Advertisements

Epigenetics Xiaole Shirley Liu STAT115, STAT215, BIO298, BIST520.
Fragile X Syndrome (Martin-Bell Syndrome)
Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells Robertson K. et al. Human Molecular Genetics, 2002 Gergana Ugrinova.
Estrogen and its receptors play an important role in breast carcinogenesis. In humans, there are two subtypes of estrogen receptors (ER), ER  and ER ,
DNA Methylation Assays High Throughput Data Analysis BIOS , VCU Winter 2010 Mark Reimers, PhD.
Epigenetics Lab December 1, 2008 Goals of today’s lab: 1.Understand the basic molecular techniques used in the lab to study epigenetic silencing in cancer.
Vidyadhar Karmarkar Genomics and Bioinformatics 414 Life Sciences Building, Huck Institute of Life Sciences.
Microarrays and Their Uses Brad Windle, Ph.D
Epigenetic Control of Tamoxifen Resistant Breast Cancer Kristin Williams Arcaro Lab Thesis Resarch June 25, 2012 Kristin Williams Arcaro Lab Thesis Resarch.
Analysis of protein-DNA interactions with tiling microarrays
Trends Biomedical Science
Supplementary Table S1. Patient demographics of the RRBS discovery set. Characteristics RRBS discovery set TotalIDH1/2 WT IDH1 MUT No. of Patients
Figure S1 (a) Maspin promotor methylation status before and after treatment with 5-aza-dC (5 µM) in C33A cells visualized with a MSP. (b) C13ORF18 promotor.
INTERPRETING GENETIC MUTATIONAL DATA FOR CLINICAL ONCOLOGY Ben Ho Park, M.D., Ph.D. Associate Professor of Oncology Johns Hopkins University May 2014.
EPIGENETIC REGULATION OF MICRORNA EXPRESSION IN PROSTATE CANCER Seodhna M. Lynch 1, Karla M. O’Neill 1, Michael M. McKenna 2, Colum P. Walsh 1, Declan.
Discovery of Novel Methylated Genes in Cervical Carcinogenesis: Methylation of GREM1 and NID2 is Detected in the Majority of Invasive Cervical Cancers.
ChIP-seq Downstream Analysis Xiaole Shirley Liu STAT115, STAT215, BIO298, BIST520.
Epigenetics of cancer Vilja ja Mia.
Volume 3, Issue 4, Pages (April 2013)
Role of DNA Methylation in the Development of Diffuse-Type Gastric Cancer Digestion 2011;83:241–249 - DOI: / Fig. 1.a DNA methyltransferases.
Volume 2, Issue 10, Pages (October 2015)
Distribution of CpG dinucleotide in the human genome and differences in methylation patterns between normal and tumor cells. In the majority of the mammalian.
Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling  Baoping Cao, MD, PhD, Weili Yang,
The Role of MGMT Testing in Clinical Practice
Promoter Methylation and Differential Expression of π-Class Glutathione S-Transferase in Endometrial Carcinoma  Queeny K.Y. Chan, Ui-Soon Khoo, Kelvin.
Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability  Yasuyuki Miyakura,
Natalia Kholod, Jacques Boniver, Philippe Delvenne 
Volume 138, Issue 5, Pages e4 (May 2010)
Epigenetic mechanisms silence a disintegrin and metalloprotease 33 expression in bronchial epithelial cells  Youwen Yang, PhD, Hans Michael Haitchi, MD,
Volume 133, Issue 6, Pages (December 2007)
Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal Cancer  TaeJeong Oh, Nayoung.
Volume 136, Issue 2, Pages e1 (February 2009)
Volume 3, Issue 4, Pages (April 2013)
Volume 116, Issue 2, Pages (February 1999)
Volume 146, Issue 7, Pages e5 (June 2014)
Epigenetic Inhibition of Nuclear Receptor Small Heterodimer Partner Is Associated With and Regulates Hepatocellular Carcinoma Growth  Nan He, Kyungtae.
Genetics supersedes epigenetics in colon cancer phenotype
Copy-number alterations in an archival breast cancer sample.
Ying-Ying Yu, Ph. D. , Cui-Xiang Sun, Ph. D. , Yin-Kun Liu, Ph. D
Genomewide DNA Methylation Analysis Identifies Novel Methylated Genes in Non– Small-Cell Lung Carcinomas  Rejane Hughes Carvalho, PhD, Jun Hou, PhD, Vanja.
Benjamin P. Song, Surbhi Jain, Selena Y. Lin, Quan Chen, Timothy M
Epigenetic regulation of miR-193b in liposarcomagenesis.
Volume 121, Issue 6, Pages (December 2001)
Custom-Designed MLPA Using Multiple Short Synthetic Probes
Volume 137, Issue 1, Pages (July 2009)
Volume 23, Issue 1, Pages 9-22 (January 2013)
Genetics supersedes epigenetics in colon cancer phenotype
Germline Epigenetic Silencing of the Tumor Suppressor Gene PTPRJ in Early-Onset Familial Colorectal Cancer  Ramprasath Venkatachalam  Gastroenterology 
Inflammation-Associated Cancer Development in Digestive Organs: Mechanisms and Roles for Genetic and Epigenetic Modulation  Tsutomu Chiba, Hiroyuki Marusawa,
Volume 12, Issue 5, Pages (November 2007)
Volume 130, Issue 7, Pages (June 2006)
Increased DNA Methylation at the AXIN1 Gene in a Monozygotic Twin from a Pair Discordant for a Caudal Duplication Anomaly  N.A. Oates, J. van Vliet, D.L.
Epigenetic Control of the S100A6 (Calcyclin) Gene Expression
The human GPR109A promoter is methylated and GPR109A expression is silenced in human colon carcinoma cells. The human GPR109A promoter is methylated and.
Volume 124, Issue 5, Pages (May 2003)
Imprinting of Human GRB10 and Its Mutations in Two Patients with Russell-Silver Syndrome  Hiroshi Yoshihashi, Katsuhiro Maeyama, Rika Kosaki, Tsutomu.
Volume 131, Issue 6, Pages (December 2006)
Functional Modulation of IGF-Binding Protein-3 Expression in Melanoma
A Role for Epigenetics in Psoriasis: Methylated Cytosine–Guanine Sites Differentiate Lesional from Nonlesional Skin and from Normal Skin  Johann E. Gudjonsson,
Molecular Therapy - Nucleic Acids
BRCA1 promoter methylation detected in the peripheral blood and corresponding tumor. BRCA1 promoter methylation detected in the peripheral blood and corresponding.
Methylation status of IGFBPL1 in human breast cancer.
PTENP1 expression is downregulated in ccRCC.
Epigenetic regulation of p16INK4a in human gastric cancer.
DNA hypermethylation silences TRAIL in transformed cells.
A, high-resolution methylation analysis of ZNF545 promoter by BGS in representative carcinoma cell lines. A, high-resolution methylation analysis of ZNF545.
The ACIN1 Gene is Hypermethylated in Early Stage Lung Adenocarcinoma
DNA demethylation reactivates GSN expression in gastric cancer cells.
CpG Methylation Analysis—Current Status of Clinical Assays and Potential Applications in Molecular Diagnostics  Antonia R. Sepulveda, Dan Jones, Shuji.
Presentation transcript:

Methylation of individual CpG sites within p16 CpG islands in various human gastric lesions Zheming Lu( 陆哲明) Dajun Deng (邓大君) Beijing University School of Oncology Beijing Institute for Cancer Research,Beijing Cancer Hospital

R Beroukhim et al. Nature 463, (2010) Identification of significant focal SCNAs across 3131 human cancer specimens

p16 is inactivated by genetic alterations (10%) and DNA methylation (30%) in many human tumors (Esteller, Oncogene 2002)

Methylation status of individual CpG sites within p16 CpG islands in vivo is not well characterized. p16 is fully methylated in many cancer cell lines.Methylation status of individual CpG sites within p16 CpG islands in vivo is not well characterized. p16 is fully methylated in many cancer cell lines. The mechanisms lead to fate diversities of p16 methylation in different gastric lesions are unknown. p16 methylation is stable in cancer cells, but unstable in gastritis lesions.The mechanisms lead to fate diversities of p16 methylation in different gastric lesions are unknown. p16 methylation is stable in cancer cells, but unstable in gastritis lesions.

(Wong et al., 1999 MCB) (Human mammary epithelial cell strains, immortalized with HPV16 E6/E7 transfection)

(Luo et al., 2006 Lab Invest) M-p16 U-p16 Proportion of M-p16 (35 CpG sites) T12: 0% T14: 7.89% T74: 28.91% T67: 39.14% (Human gastric carcinoma tissues)

Analyzed fragment of p16 CpG island by partial-MSP (-355nt~+233nt, including 45+3 CpG sites) partial-MSP primer set to enrich p16 CpG islands with methylated cytosines 126bp-MSP 151bp-MSP 234bp-MSP83bp-MSP 392bp-DHPLC

More p16 partial-MSP products was detected in gastric carcinomas than in normal/gastritis 36/40 (90.0)Gastric carcinoma < /45 (42.2) 7/13 (53.8) Partial-MSP positive rate (%) Chronic gastritis Normal Pathological changes P-value (two-sides) M F0310 F0342 F0350 F0414 F0438 F0144 F0566 F bp

(H.pylori-specific 23S rDNA by PCR assay [Liu et al., 2008 BMC Microb] ) F0437 F0815 F1023 F1069 F0973 F0985 F0747 F0867 F1141 F1143 F1011 F0749 F0597 F bp More p16 partial-MSP products were detected in the Hp-positive samples than -negative ones 144negative 1530positive Hp negativepositive Partial-MSP (p<0.001)

Methylation status of individual CpG sites within p16 CpG island in human gastric mucosa (n=51) Ca (n=31) Gastritis (n=14) Normal (n=6)

Methylation status of individual CpG sites within p16 CpG island in human gastric mucosa * * G/A ( p<0.05)

* * * * * * * * * H. pylori infection and p16 methylation Normal or gastritis tissues: n Hp(+) =13, n Hp(-) = 7 Gastric carcinomas: n Hp(+) =17, n Hp(-) = 9 (*: p<0.05) (*: p=0.06) G/A

Distribution of p16 clones with different no. of methylated CpG sites in gastric mucosa

p16 clones with  6 methylated CpG sites in gastric mucosa Carcinoma [77/460; 16.7%] Gastritis [18/217; 8.3%] Normal [5/67; 7.5%]

88bp 83bp M U M U M U M U M U M.Ctrl U.Ctrl TE buffer Sample-1 Sample-2 83bp-MSP (+)(-) partial- MSP (+)3322 (-)15 83bp-MSP (+)(-) Hp (+)2815 (-)525 Results of the 83bp-MSP assay confirm those of the partial-MSP assay (p=0.044)(p<0.0001)

Results of the 83bp-MSP assay confirm those of clone sequencing of the partial-MSP products (*: p<0.05) (n=32) (n=19) * * G/A

(Trend test, p=0.021) Methylation of p16 near its TSS region correlated with pathological changes of gastric mucosa by the new MSP assay

Nucleosome positioning of p16 CpG island by a serial of PCR assays Preparation of mono- nucleosomal DNA fragment by MNase digestion ( Bai H, et al., 2008, Chin J Cancer Res) (Fatemi et al, 2005 NAR)

Methylation status of individual CpG sites within p16 CpG island in human gastric mucosa (n=51) Carcinoma (n=31) Gastritis (n=14) Normal (n=6)

(Wong et al., 1999 MCB) (Human mammary epithelial cell strains, with HPV16 E6/E7 transfection)

Will the unmethylated p16 be methylated under its repressor pressure?Will the unmethylated p16 be methylated under its repressor pressure?

Subclone C9 Subclone E3 MGC803 AGS DAPI P16 Expression status of p16 and bikunin in AGS, MGC803, and the fused subclones

The modal chromosome number (Median) of AGS, MGC803, and a fused subclone cells Chromosome No. (n=20): 48 in AGS cells 58 in MGC803 cells 89 in fused cells

Hemi-methylated CpG islands of p16 and bikunin in the fused subclones by bisulfite-clone sequencing

Methylation of CpG islands of p16 in the fused subclones by bisulfite-clone sequencing

Conclusions CpG islands of p16 are partially methylated at the protein coding nucleosomes within its exon-1 in gastritis tissues. p16 methylation could be fully extended to its 5-UTR and promoter regions in gastric carcinoma tissues. Nucleosome is the basic methylation unit of CpG islands for p16 (and other genes such as MLH1 and MT3). p16 methylation may extend from the exon-1 to promoter.

Dr. Zheming Lu: partial-MSP and extensive clone sequencing Dr. Qiang Li: fused cell subcloning Dr. Zhaojun Liu: DNA methylation detection by DHPLC; Hp by PCR Ms. Jing Zhou: 83bp-MSP and new MethyLight Cooperation with Dr. Jiafu Ji Dr. Kaifeng Pan Dr. Budong Zhu Dr. Hua Bai: nucleosome positioning Ms. Liankun Gu: pathology